• FOLLOW US
Video Player
  • Email
  • share

MannKind Snares Sanofi, Intercept Soars & Southwest's Mexico Move

MannKind signed a $925 million licensing pact with French drug maker Sanofi this week to sell its diabetes drug Afrezza. Afrezza is an inhaled powder that works faster than conventional injected forms of insulin for type 1 and type 2 diabetes. Meanwh

http://www.wgrz.com/video/3731834890001/1/MannKind-Snares-Sanofi-Intercept-Soars--Southwests-Mexico-Move http://cdn.newslook.com/d1/d19bb784fb3fa97c68ba90cca49e677b/images/frame_ext.jpg MannKind Snares Sanofi, Intercept Soars & Southwest's Mexico Move MannKind signed a $925 million licensing pact with French drug maker Sanofi this week to sell its diabetes drug Afrezza. Afrezza is an inhaled powder that works faster than conventional injected forms of insulin for type 1 and type 2 diabetes. Meanwh MexicoFinanceSanofi-Aventis S.A.youtubeYahoo!newslookcabo san lucasCancunSASY 01:30

Next Up

    

More Videos

Recent Videos

Page 1 of 5